US Digital Pathology 2022
29 September 22
| Eder Lagemann and Sidney Tate
Digital pathology for primary diagnosis is nascent in the US, but it is primed for rapid growth, similar to what is currently being seen in Europe (see KLAS’ report on global digital pathology ). In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. 33 of the interviewed organizations are live with digital pathology; the rest are currently implementing or making plans for the future.
Latest Comments See all (30) comments Filtered view: (Europe) ##.#% ##.#% ##.#% Download as Excel
Physician
Operations
Our initial experience with Sectra as a new client following the...
Physician
Product
When we implemented Sectra's solution a couple of years ago, it didn’t...
Physician
Product
The core product has a good model, and it is very stable and reliable,...
Physician
Product
The suggested product development for the system is in line with our...
Physician
Relationship, Product
Digital pathology is formed by a symbiotic relationship between the...
Physician
Relationship
Sectra’s support team is very responsive and offers solutions. They...
Physician
Operations, Product
Our recent system upgrades need to be completed without bugs. There...
Physician
Relationship
When we want developments and changes, the experience with Sectra is...
Manager
Relationship
When we first engaged with Sectra, the people at the help desk spoke...
Manager
Value
Sectra doesn't really provide value for the money, at least for us....